WCM Investment Management LLC raised its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 64.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,314,071 shares of the company's stock after purchasing an additional 1,687,100 shares during the quarter. WCM Investment Management LLC owned about 4.23% of DocGo worth $18,637,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. Geode Capital Management LLC boosted its stake in shares of DocGo by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,252,516 shares of the company's stock valued at $7,480,000 after buying an additional 39,016 shares during the period. State Street Corp raised its stake in DocGo by 4.9% during the 3rd quarter. State Street Corp now owns 1,928,972 shares of the company's stock valued at $6,404,000 after purchasing an additional 90,438 shares during the last quarter. P.A.W. Capital Corp increased its position in shares of DocGo by 1.9% during the third quarter. P.A.W. Capital Corp now owns 1,630,000 shares of the company's stock valued at $5,412,000 after purchasing an additional 30,000 shares during the period. Harbor Capital Advisors Inc. lifted its position in DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after purchasing an additional 363,391 shares during the period. Finally, Franklin Resources Inc. boosted its position in shares of DocGo by 11.6% during the 3rd quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company's stock valued at $3,933,000 after acquiring an additional 124,348 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company's stock.
DocGo Trading Down 1.8 %
NASDAQ DCGO traded down $0.10 on Wednesday, hitting $5.35. 516,206 shares of the company's stock were exchanged, compared to its average volume of 558,703. The stock has a market cap of $545.97 million, a price-to-earnings ratio of 19.11, a P/E/G ratio of 13.82 and a beta of 1.00. The stock has a 50-day moving average of $4.46 and a 200-day moving average of $3.91. DocGo Inc. has a 52 week low of $2.75 and a 52 week high of $5.61.
Analyst Upgrades and Downgrades
Separately, Needham & Company LLC restated a "buy" rating and issued a $7.00 price target on shares of DocGo in a research report on Thursday, January 16th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $6.10.
View Our Latest Report on DocGo
Insider Transactions at DocGo
In other news, General Counsel Ely D. Tendler sold 23,088 shares of the company's stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares of the company's stock, valued at $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.70% of the stock is currently owned by corporate insiders.
DocGo Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories

Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.